Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
OGSIVEO
Show more
Pharmaceutical preparations for the treatment of oncology and tumors; small molecule therapeutics in the nature of pharmaceutical preparations for the treatment of oncology and tumors
Class 5 – Pharmaceuticals & supplements
Status timeline
- 14 Sep 2021Application filedNew Application Entered
- 14 Jun 2022Assigned to an examining attorneyAssigned To Examiner
- 17 Jun 2022Office action issuedNon-Final Action Written
- 21 Jun 2022Approved for publicationApproved For Pub - Principal Register
- 26 Jul 2022Published for oppositionPublished For Opposition
- 20 Sep 2022Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 11 Jan 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 18 Sep 2023Statement-of-use extension 2 grantedSou Extension 2 Granted
- 21 Dec 2023Statement of use filedTeas Statement Of Use Received
- 5 Feb 2024Statement of use acceptedAllowed Principal Register - Sou Accepted
- 6 Feb 2024Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 12 Mar 2024Registered on the Principal RegisterRegistered-Principal Register
All 34 events
| 2025-10-16 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-10-16 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-10-16 | Teas Change Of Correspondence Received |
| 2024-03-12 | Registered-Principal Register |
| 2024-03-12 | Notice Of Registration Confirmation Emailed |
| 2024-02-06 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2024-02-05 | Allowed Principal Register - Sou Accepted |
| 2024-01-11 | Case Assigned To Intent To Use Paralegal |
| 2024-01-11 | Statement Of Use Processing Complete |
| 2023-12-21 | Teas Statement Of Use Received |
| 2023-12-21 | Use Amendment Filed |
| 2023-09-20 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-09-18 | Sou Teas Extension Received |
| 2023-09-18 | Sou Extension 2 Filed |
| 2023-09-18 | Sou Extension 2 Granted |
| 2023-01-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-01-11 | Sou Teas Extension Received |
| 2023-01-11 | Sou Extension 1 Filed |
| 2023-01-11 | Sou Extension 1 Granted |
| 2022-09-20 | Noa Mailed - Sou Required From Applicant |
| 2022-07-26 | Published For Opposition |
| 2022-07-26 | Official Gazette Publication Confirmation E-Mailed |
| 2022-07-06 | Notification Of Notice Of Publication E-Mailed |
| 2022-06-21 | Examiners Amendment -Written |
| 2022-06-21 | Examiners Amendment E-Mailed |
| 2022-06-21 | Notification Of Examiners Amendment E-Mailed |
| 2022-06-21 | Examiner's Amendment Entered |
| 2022-06-21 | Approved For Pub - Principal Register |
| 2022-06-17 | Non-Final Action Written |
| 2022-06-17 | Non-Final Action E-Mailed |
| 2022-06-17 | Notification Of Non-Final Action E-Mailed |
| 2022-06-14 | Assigned To Examiner |
| 2021-10-19 | New Application Office Supplied Data Entered |
| 2021-09-14 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of oncology and tumors; small molecule therapeutics in the nature of pharmaceutical preparations for the treatment of oncology and tumors
First use anywhere 4 Dec 2023 · First use in commerce 4 Dec 2023
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 21 Oct 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.